These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity. de Vries JJ; Bungener L; Ter Veer W; van Alphen L; van der Ley P; Wilschut J; Huckriede A Vaccine; 2009 Feb; 27(6):947-55. PubMed ID: 19059296 [TBL] [Abstract][Full Text] [Related]
5. Influenza virosomes: a flu jab for malaria? Cavanagh DR; Remarque EJ; Sauerwein RW; Hermsen CC; Luty AJ Trends Parasitol; 2008 Sep; 24(9):382-5. PubMed ID: 18684667 [TBL] [Abstract][Full Text] [Related]
19. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951 [TBL] [Abstract][Full Text] [Related]